ICPT

Intercept Pharmaceuticals, Inc.

No insider bought or sold Intercept Pharmaceuticals, Inc. in the last 12 months

$0Bought, 12 mo

$0Sold, 12 mo

Follow ICPT

ICPT over the last year

Prices for ICPT aren't in yet.

ICPT after insider buys

3 months after each buy, from the first price a copier could get.

No buys have 3 months of prices yet. A record shows here at 3.

Every filing

101 insider filings since 2016, newest first

ICPTBuy

Srinivas Akkaraju · Director

$5.0M+56.0%Mar 12

ICPTSell

Sandip Kapadia · CFO and Treasurer

$54K−8.0%Jan 5

ICPTSell

Sandip Kapadia · CFO and Treasurer

$58K−6.0%Dec 16

ICPTSell

Jason Campagna · Chief Medical Officer

$57K−12.0%Aug 20

ICPTSell

S.p.a. Genextra · 10% owner

$71.2M−27.0%Aug 17

ICPTSell

Francesco Micheli · 10% owner

$71.2M−27.0%Aug 17

ICPTSell

Paolo Fundaro · Director and 10% owner

$71.2M−27.0%Aug 17

ICPTSell

Paolo Fundaro · Director and 10% owner

$50.4M−10.0%May 15

ICPTSell

Francesco Micheli · 10% owner

$50.4M−10.0%May 15

ICPTSell

S.p.a. Genextra · 10% owner

$50.4M−10.0%May 15

ICPTSell

Christian Weyer · EVP, Research, Development

$68K−4.0%Jan 27

ICPTSell

Jason Campagna · Chief Medical Officer

$83K−10.0%Jan 8

ICPTSell

Gail Cawkwell · SVP, Med Affairs, Safety, PV

David A Ford · CHRO

Christian Weyer · EVP, Research, Development

$195K−10.0%Dec 30

ICPTSell

Mark Pruzanski · President and CEO

$52KDec 30

ICPTSell

Christian Weyer · EVP, Research, Development

$106K−6.0%Dec 2

ICPTSell

Christian Weyer · EVP, Research, Development

$623K−28.0%Nov 27

ICPTSell

Mark Pruzanski · President and CEO

$5.0M−8.0%Nov 27

ICPTSell

Christian Weyer · EVP, Research, Development

$132K−9.0%Nov 19

ICPTSell

Ryan T Sullivan · General Counsel and Secretary

$1.0M−36.0%Nov 19

ICPTSell

Ryan T Sullivan · General Counsel and Secretary

$43K−2.0%Nov 15

ICPTSell

Christian Weyer · EVP, Research, Development

$80K−5.0%Nov 15

ICPTSell

Lisa Bright · Pres, International

David A Ford · CHRO

Lisa Bright · Pres, International

$47K−3.0%Jul 3

ICPTBuy

Luca Benatti · Director

$100K+19.0%May 14

ICPTSell

David Shapiro · Chief Medical Officer

$173K−5.0%May 3

ICPTSell

David Shapiro · Chief Medical Officer

$190K−5.0%Apr 16

ICPTSell

Lisa Bright · Pres, International

$68K−3.0%Apr 3

ICPTSell

David Shapiro · Chief Medical Officer

$65K−1.0%Apr 3

ICPTSell

Paolo Fundaro · Director

$233K−16.0%Mar 29

ICPTSell

Christian Weyer · EVP, Research, Development

$34K−2.0%Mar 1

ICPTSell

David Shapiro · Chief Medical Officer

$206K−5.0%Mar 1

ICPTSell

Srinivas Akkaraju · Director

$3.0M−10.0%Feb 21

ICPTSell

David Shapiro · Chief Medical Officer

$223K−5.0%Feb 20

ICPTSell

Lisa Bright · Pres, International

$138K−7.0%Jan 9

ICPTSell

David Shapiro · Chief Medical Officer

$46K−1.0%Jan 4

ICPTSell

David Shapiro · Chief Medical Officer

$265K−7.0%Jan 3

ICPTSell

David Shapiro · Chief Medical Officer

$213K−5.0%Dec 19

ICPTSell

Lisa Bright · Pres, International

$557K−19.0%Dec 6

ICPTSell

Francesco Micheli · 10% owner

$78.8M−11.0%Dec 3

ICPTSell

S.p.a. Genextra · 10% owner

$78.8M−11.0%Dec 3

ICPTSell

Christian Weyer · EVP, Research, Development

$153K−8.0%Nov 29

ICPTSell

Mark Pruzanski · President and CEO

$5.1M−8.0%Nov 16

ICPTSell

David Shapiro · Chief Medical Officer

$193K−5.0%Nov 2

ICPTSell

David Shapiro · Chief Medical Officer

$353K−8.0%Oct 16

ICPTSell

David Shapiro · Chief Medical Officer

$84K−2.0%Oct 5

ICPTSell

David Shapiro · Chief Medical Officer

$548K−10.0%Sep 7

ICPTBuy

Keith Michael Gottesdiener · Director

$75K+31.0%Apr 9

Older filings

Filings come from SEC EDGAR and prices from daily closes. Not investment advice.